Clinomics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Public Companies | 1,019,543 | 2.62% |
| Institutions | 1,305,468 | 3.36% |
| Individual Insiders | 2,693,229 | 6.93% |
| Private Companies | 4,896,908 | 12.6% |
| General Public | 28,967,017 | 74.5% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 21.6%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 4,896,908 | ₩3.0b | 0% | no data | |||
| 1,923,373 | ₩1.2b | -21.6% | no data | |||
| 1,305,468 | ₩809.4m | 0% | 0.05% | |||
| 1,019,543 | ₩632.1m | 0% | no data | |||
| 530,000 | ₩328.6m | 0% | no data | |||
| 159,675 | ₩99.0m | 0% | no data | |||
| 74,793 | ₩46.4m | 0% | no data | |||
| 5,388 | ₩3.3m | -98.8% | no data |